Quick Answer
CVS HEALTH Corp reported Diluted EPS of $1.39 per share for fiscal year 2025.
CVS HEALTH Corp Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $1.39 | -62.0% |
| 2024 | $3.66 | -43.4% |
| 2023 | $6.47 | +98.5% |
| 2022 | $3.26 | -45.8% |
| 2021 | $6.02 | +10.3% |
| 2020 | $5.46 | +7.5% |
| 2019 | $5.08 | +991.2% |
| 2018 | -$0.57 | -108.9% |
| 2017 | $6.44 | +31.4% |
| 2016 | $4.90 | +5.8% |
| 2015 | $4.63 | +16.9% |
| 2014 | $3.96 | +5.9% |
| 2013 | $3.74 | +23.8% |
| 2012 | $3.02 | +17.5% |
| 2011 | $2.57 | +3.2% |
| 2010 | $2.49 | -2.4% |
| 2009 | $2.55 | +17.0% |
| 2008 | $2.18 | +13.5% |
| 2007 | $1.92 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$3.13 | -4571.4% | -491.2% |
| June 30, 2025 | $0.80 | -43.3% | -43.3% |
| March 31, 2025 | $1.41 | +60.2% | +1914.3% |
| September 30, 2024 | $0.07 | -96.0% | -95.0% |
| June 30, 2024 | $1.41 | -4.7% | +60.2% |
| March 31, 2024 | $0.88 | -46.7% | -49.7% |
| September 30, 2023 | $1.75 | +167.6% | +18.2% |
| June 30, 2023 | $1.48 | -35.4% | -10.3% |
- CVS HEALTH Corp showed a decrease of -62.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2007–2025 period, CVS HEALTH Corp’s diluted eps has declined by 27.6% (from $1.92 per share to $1.39 per share).
- The most recent figure is from CVS HEALTH Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: